{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:47:30Z","timestamp":1790952450960,"version":"4.1.0"},"reference-count":85,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U01DA038886"],"award-info":[{"award-number":["U01DA038886"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U01DA021525"],"award-info":[{"award-number":["U01DA021525"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["20R74326"],"award-info":[{"award-number":["20R74326"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MSH-141971"],"award-info":[{"award-number":["MSH-141971"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010658","name":"St. Paul's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U01DA021525"],"award-info":[{"award-number":["U01DA021525"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002964","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T13:24:00Z","timestamp":1574774640000},"page":"e1002964","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":70,"title":["Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study"],"prefix":"10.1371","volume":"16","author":[{"given":"Mary Clare","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3843-2928","authenticated-orcid":true,"given":"Kanna","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3821-6221","authenticated-orcid":true,"given":"M-J","family":"Milloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0870-7153","authenticated-orcid":true,"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,11,26]]},"reference":[{"issue":"2","key":"pmed.1002964.ref001","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2471\/BLT.12.108282","article-title":"Mortality among people who inject drugs: a systematic review and meta-analysis","volume":"91","author":"BM Mathers","year":"2013","journal-title":"Bull World Health Organ"},{"key":"pmed.1002964.ref002","author":"Health Canada","year":"2019"},{"key":"pmed.1002964.ref003","author":"National Institute on Drug Abuse","year":"2019"},{"key":"pmed.1002964.ref004","author":"Statistics Canada","year":"2019"},{"key":"pmed.1002964.ref005","author":"S Darke","year":"2006"},{"issue":"6","key":"pmed.1002964.ref006","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/aje\/kwv207","article-title":"Sex-based differences in rates, causes, and predictors of death among injection drug users in Vancouver, Canada","volume":"183","author":"K Hayashi","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"11","key":"pmed.1002964.ref007","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/archinte.164.11.1214","article-title":"Changing patterns in causes of death in a cohort of injecting drug users, 1980\u20132001","volume":"164","author":"L Copeland","year":"2004","journal-title":"Arch Intern Med"},{"key":"pmed.1002964.ref008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7517-4-1","article-title":"Factors associated with premature mortality among young injection drug users in Vancouver.","volume":"4","author":"CL Miller","year":"2007","journal-title":"Harm Reduct J"},{"issue":"6","key":"pmed.1002964.ref009","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2105\/AJPH.2014.302473","article-title":"High mortality among non-HIV-infected people who inject drugs in Bangkok, Thailand, 2005\u20132012.","volume":"105","author":"S Vanichseni","year":"2015","journal-title":"Am J Public Health"},{"key":"pmed.1002964.ref010","volume-title":"Drug consumption rooms: an overview of provision and evidence","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2018"},{"issue":"5","key":"pmed.1002964.ref011","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11904-017-0363-y","article-title":"Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review.","volume":"14","author":"MC Kennedy","year":"2017","journal-title":"Curr HIV\/AIDS Rep"},{"key":"pmed.1002964.ref012","volume-title":"Supervised consumption sites: status of applications","author":"Health Canada","year":"2019"},{"issue":"9","key":"pmed.1002964.ref013","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1111\/add.14664","article-title":"Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic","volume":"114","author":"MA Irvine","year":"2019","journal-title":"Addiction"},{"key":"pmed.1002964.ref014","article-title":"Ontario announces 15 overdose prevention sites across the province","author":"C Perkel","year":"2019","journal-title":"National Post"},{"key":"pmed.1002964.ref015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s41124-018-0035-6","article-title":"Drug consumption rooms (DCRs) as a setting to address hepatitis C\u2014findings from an international online survey","volume":"3","author":"V Belackova","year":"2018","journal-title":"Hepatol Med Policy"},{"key":"pmed.1002964.ref016","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12954-017-0154-1","article-title":"Supervised injection facilities in Canada: past, present, and future","volume":"14","author":"T Kerr","year":"2017","journal-title":"Harm Reduct J"},{"key":"pmed.1002964.ref017","author":"Vancouver Coastal Health.","year":"2019"},{"key":"pmed.1002964.ref018","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugpo.2017.12.005","article-title":"Using drugs in un\/safe spaces: impact of perceived illegality on an underground supervised injecting facility in the United States.","volume":"53","author":"PJ Davidson","year":"2018","journal-title":"Int J Drug Policy"},{"key":"pmed.1002964.ref019","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","article-title":"Supervised injection services: what has been demonstrated? A systematic literature review","volume":"145","author":"C Potier","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"pmed.1002964.ref020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.socscimed.2014.01.051","article-title":"\u2018Safer environment interventions\u2019: a qualitative synthesis of the experiences and perceptions of people who inject drugs","volume":"106","author":"R McNeil","year":"2014","journal-title":"Soc Sci Med"},{"issue":"4","key":"pmed.1002964.ref021","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1360-0443.2008.02474.x","article-title":"Use of supervised injection facilities and injection risk behaviours among young drug injectors","volume":"104","author":"MJ Bravo","year":"2009","journal-title":"Addiction"},{"issue":"3","key":"pmed.1002964.ref022","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/002204260303300306","article-title":"The Sydney Medically Supervised Injecting Centre: client characteristics and predictors of frequent attendance during the first 12 months of operation","volume":"33","author":"J Kimber","year":"2003","journal-title":"J Drug Issues"},{"issue":"5","key":"pmed.1002964.ref023","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.drugpo.2009.01.001","article-title":"Drug consumption facility as part of a primary health care centre for problem drug users\u2014which clients are attracted?","volume":"20","author":"N Scherbaum","year":"2009","journal-title":"Int J Drug Policy"},{"issue":"3","key":"pmed.1002964.ref024","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.amepre.2019.04.024","article-title":"Supervised injection facility utilization patterns: a prospective cohort study in Vancouver, Canada","volume":"57","author":"MC Kennedy","year":"2019","journal-title":"Am J Prev Med"},{"issue":"5","key":"pmed.1002964.ref025","doi-asserted-by":"crossref","first-page":"770","DOI":"10.2105\/AJPH.2004.057828","article-title":"Service uptake and characteristics of injection drug users utilizing North America\u2019s first medically supervised safer injecting facility","volume":"96","author":"E Wood","year":"2006","journal-title":"Am J Public Health"},{"issue":"2","key":"pmed.1002964.ref026","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.amepre.2005.04.011","article-title":"Do supervised injecting facilities attract higher-risk injection drug users?","volume":"29","author":"E Wood","year":"2005","journal-title":"Am J Prev Med"},{"issue":"10","key":"pmed.1002964.ref027","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/archinte.161.10.1281","article-title":"Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective","volume":"161","author":"SA Strathdee","year":"2001","journal-title":"Arch Intern Med"},{"issue":"6","key":"pmed.1002964.ref028","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00002030-200304110-00014","article-title":"Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic","volume":"17","author":"MW Tyndall","year":"2003","journal-title":"AIDS"},{"issue":"1","key":"pmed.1002964.ref029","doi-asserted-by":"crossref","first-page":"e54910","DOI":"10.1371\/journal.pone.0054910","article-title":"Frailty, HIV infection, and mortality in an aging cohort of injection drug users","volume":"8","author":"DA Piggott","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"pmed.1002964.ref030","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.drugalcdep.2013.03.009","article-title":"The longitudinal association between homelessness, injection drug use, and injection-related risk behavior among persons with a history of injection drug use in Baltimore, MD","volume":"132","author":"SL Linton","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"pmed.1002964.ref031","first-page":"S135","article-title":"Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration","volume":"117","author":"S Galea","year":"2002","journal-title":"Public Health Rep"},{"issue":"9482","key":"pmed.1002964.ref032","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(05)66475-6","article-title":"Safer injection facility use and syringe sharing in injection drug users","volume":"366","author":"T Kerr","year":"2005","journal-title":"Lancet"},{"issue":"23","key":"pmed.1002964.ref033","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1056\/NEJMc052939","article-title":"Attendance at supervised injecting facilities and use of detoxification services","volume":"354","author":"E Wood","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"pmed.1002964.ref034","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1360-0443.2007.01818.x","article-title":"Rate of detoxification service use and its impact among a cohort of supervised injecting facility users","volume":"102","author":"E Wood","year":"2007","journal-title":"Addiction"},{"issue":"2\u20133","key":"pmed.1002964.ref035","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugalcdep.2010.07.023","article-title":"Injection drug use cessation and use of North America\u2019s first medically supervised safer injecting facility","volume":"113","author":"K DeBeck","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"pmed.1002964.ref036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2017.08.003","article-title":"Use of on-site detoxification services co-located with a supervised injection facility","volume":"82","author":"A Gaddis","year":"2017","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"pmed.1002964.ref037","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/1471-2458-10-327","article-title":"Determinants of hospitalization for a cutaneous injection-related infection among injection drug users: a cohort study","volume":"10","author":"E Lloyd-Smith","year":"2010","journal-title":"BMC Public Health"},{"key":"pmed.1002964.ref038","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1874279301206010005","article-title":"Determinants of cutaneous injection-related infections among injection drug users at an emergency department","volume":"6","author":"E Lloyd-Smith","year":"2012","journal-title":"Open Infect Dis J"},{"issue":"6","key":"pmed.1002964.ref039","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/09595230801995668","article-title":"Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre","volume":"27","author":"J Kimber","year":"2008","journal-title":"Drug Alcohol Rev"},{"key":"pmed.1002964.ref040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000068807","article-title":"Drug consumption rooms in Rotterdam: an explorative description","volume":"9","author":"A van der Poel","year":"2003","journal-title":"Eur Addict Res"},{"issue":"3","key":"pmed.1002964.ref041","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/002204260303300308","article-title":"Drug consumption rooms in Hamburg, Germany: evaluation of the effects on harm reduction and the reduction of public nuisance","volume":"33","author":"H Zurhold","year":"2003","journal-title":"J Drug Issues"},{"key":"pmed.1002964.ref042","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12954-016-0115-0","article-title":"A cross-sectional national survey assessing self-reported drug intake behavior, contact with the primary sector and drug treatment among service users of Danish drug consumption rooms","volume":"13","author":"EC Toth","year":"2016","journal-title":"Harm Reduct J"},{"key":"pmed.1002964.ref043","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1477-7517-11-29","article-title":"Self-reported changes in drug use behaviors and syringe disposal methods following the opening of a supervised injecting facility in Copenhagen, Denmark","volume":"11","author":"EN Kinnard","year":"2014","journal-title":"Harm Reduct J"},{"issue":"9775","key":"pmed.1002964.ref044","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","article-title":"Reduction in overdose mortality after the opening of North America\u2019s first medically supervised safer injecting facility: a retrospective population-based study","volume":"377","author":"BDL Marshall","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"pmed.1002964.ref045","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1360-0443.2009.02837.x","article-title":"The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia.","volume":"105","author":"AM Salmon","year":"2010","journal-title":"Addiction"},{"key":"pmed.1002964.ref046","author":"National Centre in HIV Epidemiology and Clinical Research","year":"2007"},{"key":"pmed.1002964.ref047","author":"S Poschadel","year":"2003"},{"issue":"10","key":"pmed.1002964.ref048","doi-asserted-by":"crossref","first-page":"e3351","DOI":"10.1371\/journal.pone.0003351","article-title":"Estimated drug overdose deaths averted by North America\u2019s first medically-supervised safer injection facility","volume":"3","author":"M-J Milloy","year":"2008","journal-title":"PLoS ONE"},{"key":"pmed.1002964.ref049","author":"D Hedrich","year":"2004"},{"issue":"6","key":"pmed.1002964.ref050","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/jama.280.6.547","article-title":"Barriers to use of free antiretroviral therapy in injection drug users","volume":"280","author":"SA Strathdee","year":"1998","journal-title":"JAMA"},{"issue":"4","key":"pmed.1002964.ref051","first-page":"405","article-title":"Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?","volume":"165","author":"E Wood","year":"2001","journal-title":"Can Med Assoc J"},{"issue":"2","key":"pmed.1002964.ref052","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.amjmed.2006.02.030","article-title":"Frequent needle exchange use and HIV incidence in Vancouver, Canada","volume":"120","author":"E Wood","year":"2007","journal-title":"Am J Med"},{"issue":"8","key":"pmed.1002964.ref053","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jama.2010.1205","article-title":"Minimizing bias due to confounding by indication in comparative effectiveness research: the importance of restriction","volume":"304","author":"BM Psaty","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"pmed.1002964.ref054","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/ije\/dys223","article-title":"Why representativeness should be avoided.","volume":"42","author":"KJ Rothman","year":"2013","journal-title":"Int J Epidemiol"},{"issue":"1","key":"pmed.1002964.ref055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/aje\/kwu485","article-title":"Controlling time-dependent confounding by health status and frailty: restriction versus statistical adjustment","volume":"182","author":"LJ McGrath","year":"2015","journal-title":"Am J Epidemiol"},{"key":"pmed.1002964.ref056","article-title":"Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research.","author":"MH Secrest","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"pmed.1002964.ref057","author":"National Institute on Alcohol Abuse and Alcoholism","year":"2016"},{"key":"pmed.1002964.ref058","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12889-015-1479-x","article-title":"Impact of unstable housing on all-cause mortality among persons who inject drugs","volume":"15","author":"R Zivanovic","year":"2015","journal-title":"BMC Public Health"},{"key":"pmed.1002964.ref059","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1186\/1471-2458-14-1153","article-title":"The impact of drug use patterns on mortality among polysubstance users in a Canadian setting: a prospective cohort study.","volume":"14","author":"A Hayden","year":"2014","journal-title":"BMC Public Health"},{"key":"pmed.1002964.ref060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2458-8-116","article-title":"Calculating expected years of life lost for assessing local ethnic disparities in causes of premature death","volume":"8","author":"TJ Arag\u00f3n","year":"2008","journal-title":"BMC Public Health"},{"issue":"11","key":"pmed.1002964.ref061","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1111\/j.1360-0443.2010.03077.x","article-title":"Elevated overdose mortality rates among First Nations individuals in a Canadian setting: a population-based analysis","volume":"105","author":"M-J Milloy","year":"2010","journal-title":"Addiction"},{"issue":"3","key":"pmed.1002964.ref062","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/01.aids.0000206508.32030.92","article-title":"Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia","volume":"20","author":"E Lloyd-Smith","year":"2006","journal-title":"AIDS"},{"issue":"1","key":"pmed.1002964.ref063","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/pubmed\/fdl090","article-title":"Changes in injecting practices associated with the use of a medically supervised safer injection facility","volume":"29","author":"J-A Stoltz","year":"2007","journal-title":"J Public Health"},{"key":"pmed.1002964.ref064","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"L Sordo","year":"2017","journal-title":"BMJ"},{"issue":"4","key":"pmed.1002964.ref065","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2105\/AJPH.2010.197038","article-title":"Surviving drug addiction: the effect of treatment and abstinence on mortality.","volume":"101","author":"CK Scott","year":"2011","journal-title":"Am J Public Health"},{"issue":"4","key":"pmed.1002964.ref066","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/acps.13088","article-title":"Reduction in mortality risk with opioid agonist therapy: a systematic review and meta\u2010analysis","volume":"140","author":"A Bahji","year":"2019","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"pmed.1002964.ref067","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugalcdep.2005.11.011","article-title":"Attendance, drug use patterns, and referrals made from North America\u2019s first supervised injection facility","volume":"83","author":"MW Tyndall","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"pmed.1002964.ref068","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12954-018-0252-8","article-title":"Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada","volume":"15","author":"M Karamouzian","year":"2018","journal-title":"Harm Reduct J"},{"key":"pmed.1002964.ref069","doi-asserted-by":"crossref","first-page":"18855","DOI":"10.7448\/IAS.17.1.18855","article-title":"Impact of supervised drug consumption services on access to and engagement with care at a palliative and supportive care facility for people living with HIV\/AIDS: a qualitative study","volume":"17","author":"R McNeil","year":"2014","journal-title":"J Int AIDS Soc"},{"issue":"1\u20132","key":"pmed.1002964.ref070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.drugalcdep.2008.05.014","article-title":"Accessing care for injection-related infections through a medically supervised injecting facility: a qualitative study","volume":"98","author":"W Small","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"pmed.1002964.ref071","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.annepidem.2009.03.007","article-title":"Determinants of cutaneous injection-related infection care at a supervised injecting facility","volume":"19","author":"E Lloyd-Smith","year":"2009","journal-title":"Ann Epidemiol"},{"issue":"4","key":"pmed.1002964.ref072","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1465-3362.2009.00025.x","article-title":"Access to health and social services for IDU: the impact of a medically supervised injection facility","volume":"28","author":"W Small","year":"2009","journal-title":"Drug Alcohol Rev"},{"issue":"5","key":"pmed.1002964.ref073","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.addbeh.2006.07.013","article-title":"Injection drug users\u2019 perceptions regarding use of a medically supervised safer injecting facility","volume":"32","author":"S Petrar","year":"2007","journal-title":"Addict Behav"},{"issue":"6","key":"pmed.1002964.ref074","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/1049732311400919","article-title":"Injection drug users\u2019 access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture.","volume":"21","author":"W Small","year":"2011","journal-title":"Qual Health Res"},{"issue":"11","key":"pmed.1002964.ref075","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1503\/cmaj.060863","article-title":"Summary of findings from the evaluation of a pilot medically supervised safer injecting facility","volume":"175","author":"E Wood","year":"2006","journal-title":"Can Med Assoc J"},{"key":"pmed.1002964.ref076","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1477-7517-7-20","article-title":"Social structural factors that shape assisted injecting practices among injection drug users in Vancouver, Canada: a qualitative study","volume":"7","author":"N Fairbairn","year":"2010","journal-title":"Harm Reduct J"},{"issue":"34","key":"pmed.1002964.ref077","doi-asserted-by":"crossref","first-page":"E1083","DOI":"10.1503\/cmaj.170659","article-title":"It\u2019s time to allow assisted injection in supervised injection sites","volume":"189","author":"M Gagnon","year":"2017","journal-title":"CMAJ"},{"issue":"8","key":"pmed.1002964.ref078","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/hiv.12493","article-title":"The effect of engagement in an HIV\/AIDS integrated health programme on plasma HIV-1 RNA suppression among HIV-positive people who use illicit drugs: a marginal structural modelling analysis","volume":"18","author":"L Ti","year":"2017","journal-title":"HIV Med"},{"issue":"1","key":"pmed.1002964.ref079","doi-asserted-by":"crossref","first-page":"21407","DOI":"10.7448\/IAS.20.1.21407","article-title":"Integrated HIV care and service engagement among people living with HIV who use drugs in a setting with a community-wide treatment as prevention initiative: a qualitative study in Vancouver, Canada","volume":"20","author":"AB Collins","year":"2017","journal-title":"J Int AIDS Soc"},{"issue":"S1","key":"pmed.1002964.ref080","first-page":"67","article-title":"Distributing \u201ctake home\u201d naloxone via Sydney medically supervised injecting centre: where to from here?","volume":"34","author":"W Wood","year":"2015","journal-title":"Drug Alcohol Rev"},{"key":"pmed.1002964.ref081","article-title":"Toxicology backlog delaying drug overdose test results","author":"D Wilson","year":"2017","journal-title":"CBC News"},{"issue":"4","key":"pmed.1002964.ref082","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the e-value","volume":"167","author":"TJ VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"pmed.1002964.ref083","article-title":"Policing space in the overdose crisis: a rapid ethnographic study of the impact of law enforcement practices on the effectiveness of overdose prevention sites","author":"AB Collins","year":"2019","journal-title":"Int J Drug Policy"},{"issue":"3","key":"pmed.1002964.ref084","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.drugpo.2013.11.006","article-title":"Negotiating place and gendered violence in Canada\u2019s largest open drug scene","volume":"25","author":"R McNeil","year":"2014","journal-title":"Int J Drug Policy"},{"key":"pmed.1002964.ref085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.healthplace.2015.07.006","article-title":"Area restrictions, risk, harm, and health care access among people who use drugs in Vancouver, Canada: a spatially oriented qualitative study","volume":"35","author":"R McNeil","year":"2015","journal-title":"Health Place"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T13:24:21Z","timestamp":1574774661000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002964"}},"subtitle":[],"editor":[{"given":"Alexander C.","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,11,26]]},"references-count":85,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002964","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,26]]}}}